NASDAQ:CGNT Cognyte Software (CGNT) Stock Forecast, Price & News $5.21 -0.19 (-3.52%) (As of 06/7/2023 ET) Add Compare Share Share Today's Range$5.16▼$5.4550-Day Range$3.10▼$5.4052-Week Range$2.31▼$7.28Volume553,739 shsAverage Volume240,044 shsMarket Capitalization$358.66 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Cognyte Software MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside42.4% Downside$3.00 Price TargetShort InterestHealthy0.77% of Float Sold ShortDividend StrengthN/ASustainability-0.83Upright™ Environmental ScoreNews Sentiment0.53Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.58 out of 5 starsComputer And Technology Sector507th out of 598 stocksPrepackaged Software Industry167th out of 211 stocks 1.0 Analyst's Opinion Consensus RatingCognyte Software has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.00, Cognyte Software has a forecasted downside of 42.4% from its current price of $5.21.Amount of Analyst CoverageCognyte Software has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.77% of the float of Cognyte Software has been sold short.Short Interest Ratio / Days to CoverCognyte Software has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cognyte Software has recently decreased by 18.08%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCognyte Software does not currently pay a dividend.Dividend GrowthCognyte Software does not have a long track record of dividend growth. Previous Next 3.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCognyte Software has received a 29.75% net impact score from Upright. Cognyte Software seems to create the most significant positive value in categories "Jobs", "Taxes", and "Knowledge infrastructure". The positive contribution in the "Knowledge infrastructure" impact category is false driven by its "Predictive analytics software" product. See details.Environmental SustainabilityThe Environmental Impact score for Cognyte Software is -0.83. Previous Next 3.1 News and Social Media Coverage News SentimentCognyte Software has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cognyte Software this week, compared to 2 articles on an average week.Search Interest1 people have searched for CGNT on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Cognyte Software to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cognyte Software insiders have not sold or bought any company stock.Percentage Held by Institutions84.93% of the stock of Cognyte Software is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cognyte Software is -3.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cognyte Software is -3.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCognyte Software has a P/B Ratio of 1.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cognyte Software (NASDAQ:CGNT) StockCognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions. Its solutions are designed to support various use cases and support a range of users, including data analysts, investigation managers, and security operations center operators, as well as operational field teams. In addition, the company provides customer support, professional, and integration services. Its government customers include national, regional, and local government agencies; and enterprise customers consist of commercial and physical security customers. The company was incorporated in 2020 and is headquartered in Herzliya, Israel.Read More Receive CGNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cognyte Software and its competitors with MarketBeat's FREE daily newsletter. Email Address CGNT Stock News HeadlinesJune 7, 2023 | finance.yahoo.comCognyte to Announce First Quarter FY2024 Financial Results on June 15, 2023May 14, 2023 | americanbankingnews.comCognyte Software (NASDAQ:CGNT) Stock Rating Upgraded by StockNews.comJune 8, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.May 10, 2023 | finance.yahoo.comCognyte Software Ltd. (NASDAQ:CGNT) is favoured by institutional owners who hold 52% of the companyMay 9, 2023 | finance.yahoo.comCognyte Announces Appointment of Avi Cohen to Board of DirectorsMay 8, 2023 | americanbankingnews.comCognyte Software (NASDAQ:CGNT) vs. CareCloud (NASDAQ:CCLD) Critical AnalysisMay 7, 2023 | americanbankingnews.comCognyte Software (NASDAQ:CGNT) Downgraded by StockNews.comMay 2, 2023 | marketwatch.comBronstein, Gewirtz & Grossman, LLC Reminds Cognyte Software Ltd. (CGNT) Investors of Class Action and Last Few Hours to Actively ParticipateJune 8, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.April 28, 2023 | technews.tmcnet.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cognyte Software Ltd. (CGNT)April 28, 2023 | benzinga.comDeadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Cognyte Software Ltd. (CGNT) Investors of Filing Deadline in Class Action LawsuitApril 24, 2023 | barrons.com7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Cognyte Software Ltd. with Losses of $100,000 to Contact the FirmApril 22, 2023 | markets.businessinsider.comCGNT ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Cognyte Software Ltd.April 17, 2023 | theglobeandmail.comKessler Topaz Meltzer & Check, LLP: Deadline Reminder for Cognyte Software Ltd. (CGNT) InvestorsApril 17, 2023 | americanbankingnews.comCognyte Software (NASDAQ:CGNT) Upgraded at StockNews.comApril 16, 2023 | benzinga.comROSEN, A LEADING LAW FIRM, Encourages Cognyte Software Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGNTApril 15, 2023 | tmcnet.comCOGNYTE DEADLINE ALERT: Securities Litigation Partner James (Josh)April 15, 2023 | americanbankingnews.comReviewing Cognyte Software (NASDAQ:CGNT) and Paylocity (NASDAQ:PCTY)April 14, 2023 | benzinga.comROSEN, A TOP RANKED FIRM, Encourages Cognyte Software Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGNTApril 13, 2023 | finance.yahoo.comIs Cognyte Software (NASDAQ:CGNT) In A Good Position To Deliver On Growth Plans?April 12, 2023 | tmcnet.comCGNT INVESTOR NOTICE: ROSEN, A GLOBALLY RECOGNIZED FIRM,April 11, 2023 | finance.yahoo.comCognyte Announces Fourth Quarter and Fiscal Year Ended January 31, 2023 ResultsApril 11, 2023 | americanbankingnews.comCognyte Software (NASDAQ:CGNT) Updates FY24 Earnings GuidanceApril 11, 2023 | americanbankingnews.comCognyte Software (NASDAQ:CGNT) Issues FY 2024 Earnings GuidanceApril 11, 2023 | americanbankingnews.comCognyte Software (NASDAQ:CGNT) Updates Q4 Earnings GuidanceApril 10, 2023 | benzinga.comLawsuit Notice: NASDAQ: CGNT Investors who lost over $200,000 with shares of Cognyte Software Ltd. should contact the Shareholders Foundation.April 7, 2023 | americanbankingnews.comFinancial Review: Cognyte Software (NASDAQ:CGNT) and ZoomInfo Technologies (NASDAQ:ZI)See More Headlines CGNT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CGNT Company Calendar Last Earnings12/20/2021Today6/07/2023Next Earnings (Estimated)6/27/2023Fiscal Year End1/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Prepackaged software Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:CGNT CUSIPN/A CIK894237 Webwww.cogentixmedical.com Phone972-9962-2300FaxN/AEmployees1,650Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.00 High Stock Price Forecast$3.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside-42.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-114,130,000.00 Net Margins-36.57% Pretax Margin-31.08% Return on Equity-55.52% Return on Assets-26.16% Debt Debt-to-Equity RatioN/A Current Ratio1.30 Quick Ratio1.17 Sales & Book Value Annual Sales$312.06 million Price / Sales1.15 Cash FlowN/A Price / Cash FlowN/A Book Value$3.05 per share Price / Book1.71Miscellaneous Outstanding Shares68,840,000Free FloatN/AMarket Cap$358.66 million OptionableNot Optionable Beta1.36 Key ExecutivesMr. Elad Sharon (Age 46)CEO & Director Mr. David Abadi (Age 48)Chief Financial Officer Mr. Ziv Levi (Age 53)Chief Legal Officer Ms. Rini Karlin (Age 50)Chief People Officer Mr. Miki Migdal (Age 61)Chief Bus. Officer Mr. Sharon Chouli (Age 52)Chief Customer Officer Mr. Avi Schechter (Age 56)Chief Revenue Officer More ExecutivesKey CompetitorsON24NYSE:ONTF2UNASDAQ:TWOUBandwidthNASDAQ:BANDBigBear.aiNYSE:BBAIRed VioletNASDAQ:RDVTView All CompetitorsInstitutional OwnershipAmeriprise Financial Inc.Bought 685,890 shares on 5/22/2023Ownership: 3.319%JPMorgan Chase & Co.Sold 48,188 shares on 5/18/2023Ownership: 0.267%Arrowstreet Capital Limited PartnershipBought 40,406 shares on 5/16/2023Ownership: 1.362%Geode Capital Management LLCBought 2,376 shares on 5/16/2023Ownership: 0.234%Susquehanna International Group LLPSold 200 shares on 5/16/2023Ownership: 0.000%View All Institutional Transactions CGNT Stock - Frequently Asked Questions Should I buy or sell Cognyte Software stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cognyte Software in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CGNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGNT, but not buy additional shares or sell existing shares. View CGNT analyst ratings or view top-rated stocks. What is Cognyte Software's stock price forecast for 2023? 2 brokers have issued 1 year price objectives for Cognyte Software's stock. Their CGNT share price forecasts range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests that the stock has a possible downside of 42.4%. View analysts price targets for CGNT or view top-rated stocks among Wall Street analysts. How have CGNT shares performed in 2023? Cognyte Software's stock was trading at $3.11 at the start of the year. Since then, CGNT shares have increased by 67.5% and is now trading at $5.21. View the best growth stocks for 2023 here. Are investors shorting Cognyte Software? Cognyte Software saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 531,600 shares, a drop of 18.1% from the April 30th total of 648,900 shares. Based on an average daily volume of 272,700 shares, the short-interest ratio is currently 1.9 days. Approximately 0.8% of the shares of the stock are short sold. View Cognyte Software's Short Interest. When is Cognyte Software's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 27th 2023. View our CGNT earnings forecast. How were Cognyte Software's earnings last quarter? Cognyte Software Ltd. (NASDAQ:CGNT) issued its earnings results on Monday, December, 20th. The medical device company reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.11. The medical device company earned $118.70 million during the quarter, compared to analyst estimates of $114.83 million. Cognyte Software had a negative trailing twelve-month return on equity of 55.52% and a negative net margin of 36.57%. The company's quarterly revenue was up 5.0% compared to the same quarter last year. What ETFs hold Cognyte Software's stock? ETFs with the largest weight of Cognyte Software (NASDAQ:CGNT) stock in their portfolio include ARK Israel Innovative Technology ETF (IZRL).ETFMG Prime Cyber Security ETF (HACK). What guidance has Cognyte Software issued on next quarter's earnings? Cognyte Software issued an update on its FY 2024 earnings guidance on Tuesday, April, 11th. The company provided EPS guidance of -$0.60--$0.60 for the period, compared to the consensus EPS estimate of -$0.69. The company issued revenue guidance of $294.00 million-$306.00 million, compared to the consensus revenue estimate of $287.53 million. What other stocks do shareholders of Cognyte Software own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cognyte Software investors own include EndoChoice (GI), Novavax (NVAX), Sorrento Therapeutics (SRNE), Exelixis (EXEL), Fc Global Realty (FCRE), Galectin Therapeutics (GALT), Immunomedics (IMMU), Iovance Biotherapeutics (IOVA), Neurocrine Biosciences (NBIX) and Nymox Pharmaceutical (NYMX). What is Cognyte Software's stock symbol? Cognyte Software trades on the NASDAQ under the ticker symbol "CGNT." Who are Cognyte Software's major shareholders? Cognyte Software's stock is owned by a number of retail and institutional investors. Top institutional investors include American Capital Management Inc. (7.14%), William Blair Investment Management LLC (4.33%), Ameriprise Financial Inc. (3.32%), Arrowstreet Capital Limited Partnership (1.36%), Dimensional Fund Advisors LP (1.01%) and BlackRock Inc. (0.91%). View institutional ownership trends. How do I buy shares of Cognyte Software? Shares of CGNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cognyte Software's stock price today? One share of CGNT stock can currently be purchased for approximately $5.21. How much money does Cognyte Software make? Cognyte Software (NASDAQ:CGNT) has a market capitalization of $358.66 million and generates $312.06 million in revenue each year. The medical device company earns $-114,130,000.00 in net income (profit) each year or ($1.69) on an earnings per share basis. How many employees does Cognyte Software have? The company employs 1,650 workers across the globe. How can I contact Cognyte Software? Cognyte Software's mailing address is 5420 FELTL ROAD, MINNETONKA MN, 55343. The official website for the company is www.cogentixmedical.com. The medical device company can be reached via phone at 972-9962-2300 or via email at ir@cogentixmedical.com. This page (NASDAQ:CGNT) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognyte Software Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.